Jenna N Whitrock

Dr. Jenna N Whitrock


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2024 in Surgery
Verified
Journal Article
Closed access
JWJenna N Whitrock
Jenna N Whitrock
CPCatherine G. Pratt
Catherine G. Pratt
MCMichela M. Carter
Michela M. Carter
RCRyan C. Chae
Ryan C. Chae
APAdam D. Price
Adam D. Price
SSShimul A. Shah
Shimul A. Shah

9 October 2024 in Surgery
Verified
Journal Article
Closed access
JWJenna N Whitrock
Jenna N Whitrock
CPCatherine G. Pratt
Catherine G. Pratt
SLSzu-Aun Long
Szu-Aun Long
MCMichela M. Carter
Michela M. Carter
JLJaime D. Lewis
Jaime D. Lewis
AHAlicia A. Heelan
Alicia A. Heelan

23 October 2023 in Surgery
Verified
Journal Article
Closed access
JWJenna N Whitrock
Jenna N Whitrock
MCMichela M. Carter
Michela M. Carter
LLLaura D. Leonard
Laura D. Leonard
JLJaime D. Lewis
Jaime D. Lewis
ESElizabeth A. Shaughnessy
Elizabeth A. Shaughnessy
AHAlicia A. Heelan
Alicia A. Heelan

11 July 2024 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
RCRyan Chae
Ryan Chae
JWJenna N Whitrock
Jenna N Whitrock
CNChristopher Nguyen
Christopher Nguyen
APAdam Price
Adam Price
DVDennis Vaysburg
Dennis Vaysburg
JCJennifer Colvin
Jennifer Colvin

8 August 2024 in Clinical Transplantation
Verified
Journal Article
Open access
JWJenna N Whitrock
Jenna N Whitrock
SSStephanie Sisak
Stephanie Sisak
CPCatherine G Pratt
Catherine G Pratt
ADAaron M. Delman
Aaron M. Delman
APAdam D. Price
Adam D. Price
RQRalph Cutler Quillin
Ralph Cutler Quillin
Background: The implementation of acuity circles (AC) in 2020 and the COVID‐19 pandemic increased the use of local surgeons to recover livers for transplant; however, the impact on liver transplant (LT) outcomes is unknown.Methods: Deceased donor adult LT recipients from the UNOS database were identified. Recipients were grouped by donor surgeon: local versus primary recovery. Patient and graft survival as well as trends in local recovery in the 2 years pre‐AC and post‐AC were assessed.Results: The utilization of local recovery in LT increased from 22.3% to 37.9% post‐AC (p < 0.01). LTs with local recovery had longer cold ischemia times (6.5 h [5.4–7.8] vs. 5.3 h [4.4–6.5], p < 0.01) and traveled further (210 miles [89–373] vs. 73 miles [11–196], p < 0.01) than those using primary recovery. Multivariate analyses revealed no differences in patient or graft survival between local and primary recovery, and between OPO and local surgeon. There was no difference in survival when comparing simultaneous liver–kidney, donation after circulatory death, MELD ≥ 30, or redo‐LT by recovery team. Recovery and utilization rates were also noted to be higher post‐AC (51.4% vs. 48.6% pre‐AC, p < 0.01) as well as when OPO surgeons recovered the allografts (72.5% vs. 66.0%, p < 0.01).Conclusion: Nearly 40% of LTs are performed using local recovery, and utilization rates and trends continue to change with changing organ‐sharing paradigms such as AC. This practice appears safe with outcomes similar to recovery by the primary team in appropriately selected recipients and may lead to increased access and the ability to transplant more livers.

30 November 2023 in HPB
Verified
Journal Article
Closed access
ADAaron M. Delman
Aaron M. Delman
JWJenna N Whitrock
Jenna N Whitrock
KTKevin M Turner
Kevin M Turner
EDEileen C. Donovan
Eileen C. Donovan
RQRalph C. Quillin
Ralph C. Quillin
GWGregory C. Wilson
Gregory C. Wilson